Dr. Jakob Dupont is a global expert in oncology and other therapeutic areas with over 25 years of experience developing therapies and programs dedicated to addressing high unmet medical needs. Prior to joining Sofinnova Investments, Dr. Dupont was Global Head of Research & Development and Executive Vice President at Atara Biotherapeutics. Prior to Atara, he served as Chief Medical Officer at Gossamer Bio. Before Gossamer Bio, Dr. Dupont served as Vice President and Global Head of Breast and Gynecologic Cancer Development for Genentech/Roche. Dr. Dupont has made significant contributions throughout his career, he has received numerous grants and awards, contributed to 14 regulatory approvals, 22 successful IND filings, co-authored 47 peer-reviewed publications, and has 18 patents.